A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Trial details
- Registry ID
- NCT05740007
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeNCT05740007 | IRWD | Phase 2 | Terminated | 2025-01-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |